Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IQSEC3 antisense RNA 1 (IQSEC3-AS1) is a long noncoding RNA gene defined by its antisense orientation to the protein-coding IQSEC3 gene. To date, its molecular function, biological role, and clinical relevance remain uncharacterized in genomics databases and published research. It is not considered a therapeutic target or biomarker, and there are no drugs, disease associations, or mechanistic insights reported. IQSEC3-AS1 serves as a formal gene entry with validated identifiers in major genomics resources but is not associated with direct clinical or pharmacological relevance[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IQSEC3 antisense RNA 1 (IQSEC3-AS1).